Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | ATPase family, AAA domain containing 5 | Starlite/ChEMBL | No references |
Homo sapiens | SMAD family member 2 | Starlite/ChEMBL | No references |
Homo sapiens | RAB9A, member RAS oncogene family | Starlite/ChEMBL | No references |
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Homo sapiens | geminin, DNA replication inhibitor | Starlite/ChEMBL | No references |
Homo sapiens | euchromatic histone-lysine N-methyltransferase 2 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus multilocularis | atpase aaa+ type core atpase aaa type core | Get druggable targets OG5_139225 | All targets in OG5_139225 |
Brugia malayi | MH2 domain containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Onchocerca volvulus | Get druggable targets OG5_131470 | All targets in OG5_131470 | |
Brugia malayi | Pre-SET motif family protein | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Trichomonas vaginalis | set domain proteins, putative | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | Get druggable targets OG5_131470 | All targets in OG5_131470 |
Loa Loa (eye worm) | MH2 domain-containing protein | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Loa Loa (eye worm) | transcription factor SMAD2 | Get druggable targets OG5_131716 | All targets in OG5_131716 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Brugia malayi | MH2 domain containing protein | SMAD family member 2 | 467 aa | 405 aa | 31.6 % |
Brugia malayi | Hypothetical 65.5 kDa Trp-Asp repeats containing protein F02E8.5 inchromosome X | geminin, DNA replication inhibitor | 209 aa | 176 aa | 27.8 % |
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Plasmodium falciparum | ras-related protein Rab-5B | RAB9A, member RAS oncogene family | 201 aa | 165 aa | 30.9 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | transcription factor SMAD2 | 0.0144 | 0.1098 | 0.2446 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.1743 | 0.4411 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 0.0203 | 0.0452 |
Trichomonas vaginalis | alpha-L-fucosidase, putative | 0.0167 | 0.1336 | 0.4885 |
Brugia malayi | Pre-SET motif family protein | 0.0251 | 0.224 | 0.499 |
Giardia lamblia | 4-alpha-glucanotransferase, amylo-alpha-1,6-glucosidase | 0.0129 | 0.0932 | 0.5 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0103 | 0.0659 | 0.6641 |
Schistosoma mansoni | alpha-l-fucosidase | 0.038 | 0.3607 | 0.9131 |
Loa Loa (eye worm) | pre-SET domain-containing protein family protein | 0.0251 | 0.224 | 0.499 |
Mycobacterium ulcerans | alpha-L-fucosidase | 0.038 | 0.3607 | 0.5 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0462 | 0.449 | 0.4102 |
Trichomonas vaginalis | maltase-glucoamylase, putative | 0.0103 | 0.0659 | 0.2166 |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0103 | 0.0659 | 0.1467 |
Schistosoma mansoni | alpha glucosidase | 0.0103 | 0.0659 | 0.1668 |
Loa Loa (eye worm) | amylo-alpha-1,6-glucosidase | 0.0063 | 0.0228 | 0.0509 |
Echinococcus granulosus | glycogen debranching enzyme | 0.0129 | 0.0932 | 0.0713 |
Echinococcus multilocularis | lysosomal alpha glucosidase | 0.0462 | 0.449 | 0.4102 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0103 | 0.0659 | 1 |
Loa Loa (eye worm) | MH2 domain-containing protein | 0.0144 | 0.1098 | 0.2446 |
Echinococcus multilocularis | glycogen debranching enzyme | 0.0129 | 0.0932 | 0.0292 |
Echinococcus granulosus | fucosidase alpha L 1 tissue | 0.038 | 0.3607 | 0.7695 |
Schistosoma mansoni | hypothetical protein | 0.0205 | 0.1743 | 0.4411 |
Loa Loa (eye worm) | alpha-L-fucosidase | 0.038 | 0.3607 | 0.8033 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.006 | 0.0203 | 0.0452 |
Trichomonas vaginalis | glycogen debranching enzyme, putative | 0.0129 | 0.0932 | 0.3262 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0103 | 0.0659 | 0.2166 |
Brugia malayi | Alpha-L-fucosidase family protein | 0.038 | 0.3607 | 0.8033 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.0119 | 0.0265 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 0.0203 | 0.0452 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0103 | 0.0659 | 0.2166 |
Schistosoma mansoni | hypothetical protein | 0.0093 | 0.0551 | 0.1395 |
Trichomonas vaginalis | set domain proteins, putative | 0.0286 | 0.2611 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0129 | 0.0932 | 0.2075 |
Entamoeba histolytica | glycosyl hydrolase, family 31 protein | 0.0103 | 0.0659 | 0.6641 |
Brugia malayi | Amylo-alpha-1,6-glucosidase family protein | 0.0129 | 0.0932 | 0.2075 |
Entamoeba histolytica | glycogen debranching enzyme, putative | 0.0129 | 0.0932 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0103 | 0.0659 | 1 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0103 | 0.0659 | 0.2166 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0103 | 0.0659 | 0.2166 |
Echinococcus multilocularis | geminin | 0.0205 | 0.1743 | 0.116 |
Echinococcus multilocularis | fucosidase, alpha L 1, tissue | 0.038 | 0.3607 | 0.3156 |
Onchocerca volvulus | 0.0286 | 0.2611 | 0.7449 | |
Loa Loa (eye worm) | glycosyl hydrolase family 31 protein | 0.0462 | 0.449 | 1 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0103 | 0.0659 | 0.1467 |
Brugia malayi | MH2 domain containing protein | 0.0144 | 0.1098 | 0.2446 |
Schistosoma mansoni | hypothetical protein | 0.0165 | 0.1323 | 0.335 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0103 | 0.0659 | 0.2166 |
Toxoplasma gondii | Amylo-alpha-1,6-glucosidase | 0.0129 | 0.0932 | 1 |
Trichomonas vaginalis | sucrase-isomaltase, putative | 0.0103 | 0.0659 | 0.2166 |
Schistosoma mansoni | alpha-glucosidase | 0.0412 | 0.395 | 1 |
Trichomonas vaginalis | alpha-L-fucosidase, putative | 0.0167 | 0.1336 | 0.4885 |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0462 | 0.449 | 1 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0066 | 0.0265 | 0.0585 |
Leishmania major | alpha glucosidase II subunit, putative | 0.0103 | 0.0659 | 1 |
Echinococcus granulosus | lysosomal alpha glucosidase | 0.0462 | 0.449 | 1 |
Trichomonas vaginalis | glycogen debranching enzyme, putative | 0.0129 | 0.0932 | 0.3262 |
Schistosoma mansoni | alpha-glucosidase | 0.0412 | 0.395 | 1 |
Trichomonas vaginalis | alpha-glucosidase, putative | 0.0103 | 0.0659 | 0.2166 |
Echinococcus granulosus | geminin | 0.0205 | 0.1743 | 0.2829 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 0.0203 | 0.0452 |
Trichomonas vaginalis | neutral alpha-glucosidase ab precursor, putative | 0.0103 | 0.0659 | 0.2166 |
Trypanosoma brucei | glucosidase, putative | 0.0103 | 0.0659 | 1 |
Onchocerca volvulus | 0.0366 | 0.3464 | 1 | |
Brugia malayi | Glycosyl hydrolases family 31 protein | 0.0052 | 0.0119 | 0.0265 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 2.2387 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 2.8184 um | PUBCHEM_BIOASSAY: qHTS Assay for Rab9 Promoter Activators. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 5.1735 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in MCF 10a normal breast cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 7.0795 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] | ChEMBL. | No reference |
Potency (functional) | 12.5893 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | 14.1254 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 14.581 uM | PubChem BioAssay. A quantitative high throughput screen for small molecules that induce DNA re-replication in SW480 colon adenocarcinoma cells. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 16.3535 uM | PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] | ChEMBL. | No reference |
Potency (functional) | 31.6228 uM | PubChem BioAssay. Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 63.0957 uM | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Rango (Ran-regulated importin-beta cargo) - Importin beta complex formation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID540273] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Homo sapiens | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.